CIK: 0002043476
Total reported value
$134.9M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ADMA | Adma Biologics INC | Stock-Healthcare | 33.10% | -11.67% | +1.87% | |
| 2 | CLLS | Cellectis - Adr | Stock-Other | 11.73% | -4.02% | — | |
| 3 | PALI | Palisade Bio INC | Stock-Other | 7.81% | +7.00% | — | |
| 4 | TSHA | Taysha Gene Therapies INC | Stock-Other | 7.31% | -1.34% | — | |
| 5 | PRAX | Praxis Precision Medicines I | Stock-Other | 7.23% | +0.71% | +5.51% | |
| 6 | SGHT | Sight Sciences INC | Stock-Other | 5.39% | -2.68% | -1.08% | |
| 7 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 5.21% | +1.07% | — | |
| 8 | GPCR | Structure Therapeutics INC | Stock-Other | 4.62% | -0.06% | — | |
| 9 | ASMB | Assembly Biosciences INC | Stock-Other | 4.41% | -0.80% | — | |
| 10 | IOVA | Iovance Biotherapeutics INC | Stock-Other | 3.02% | +0.88% | — | |
| 11 | SYRE | Spyre Therapeutics INC | Stock-Other | 2.42% | +1.32% | — | |
| 12 | AURA | Aura Biosciences INC | Stock-Other | 2.30% | +0.66% | — | |
| 13 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 2.29% | -0.19% | — | |
| 14 | ORKA | Oruka Therapeutics INC | Stock-Other | 1.68% | +1.05% | — | |
| 15 | APGE | Apogee Therapeutics INC | Stock-Other | 1.11% | -0.64% | -42.86% | |
| 16 | REPL | Replimune Group INC | Stock-Other | 0.36% | -0.21% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ADMA | Adma Biologics INC | +7.1% | +1.87% | Add |
| 2 | PRAX | Praxis Precision Medicines I | +6% | +5.51% | Add |
| 3 | CLLS | Cellectis - Adr | +4.9% | — | Unchanged |
| 4 | SGHT | Sight Sciences INC | +3% | -1.08% | Trim |
| 5 | TSHA | Taysha Gene Therapies INC | +3% | — | Unchanged |
| 6 | SYRE | Spyre Therapeutics INC | +1.2% | — | Unchanged |
| 7 | ASMB | Assembly Biosciences INC | +1.1% | — | Unchanged |
| 8 | IOVA | Iovance Biotherapeutics INC | +0.6% | — | Unchanged |
| 9 | ORKA | Oruka Therapeutics INC | +0.6% | — | Unchanged |
| 10 | REPL | Replimune Group INC | +0.2% | — | Unchanged |
| 11 | APGE | Apogee Therapeutics INC | +0.1% | -42.86% | Trim |
| 12 | AURA | Aura Biosciences INC | -0.3% | — | Unchanged |
| 13 | RARE | Ultragenyx Pharmaceutical In | -0.7% | — | Unchanged |
| 14 | ZLAB | Zai Lab Ltd-adr | -4.8% | — | Unchanged |
| 15 | LLY | Eli Lilly & Co | — | EXIT | Sold out |
| 16 | NVDA | Nvidia CORP | — | EXIT | Sold out |
| 17 | AKRO | Akero Therapeutics INC | — | EXIT | Sold out |
| 18 | PALI | Palisade Bio INC | — | NEW | New buy |
| 19 | GPCR | Structure Therapeutics INC | — | NEW | New buy |
| 20 | ✓ | Nrx Pharmaceuticals INC | — | EXIT | Sold out |
| 21 | GAME | Gamesquare Holdings INC | — | EXIT | Sold out |
| 22 | INSM | Insmed INC | — | EXIT | Sold out |